Singapore: Biotechnology industry group, AusBiotech and Beacon Events, organiser of the largest resource sector investor...
Mr Robert J Braithwaite, who came to China 15 years ago, was greatly influenced following his exposure to the dragon nat...
Singapore: WHO has urged countries to invest in local research in order to develop a system of universal health coverage...
Singapore: Three cases of human infection with influenza A (H7N9) has erupted in China, notified China Health and Family...
Singapore: WuXi PharmaTech, provider of R&D capability and technology platform for pharmaceutical, biotechnology, an...
Singapore: Agnitio, a leader in healthcare sector closed-loop marketing technology, continues to expand its global pres...
Singapore: PharmaNet/i3, inVentiv Health's clinical segment, and a leading provider of clinical development services to ...
Singapore: Dr Rongxiang Xu has been awarded the Golden Biatec 2013 international award by the Informal Economic Forum (I...
Singapore: Bioscience R&D outsourcing services company WuXi PharmaTech's toxicology facility in Suzhou has received ...
Singapore: QIAGEN announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test a...
Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...
Singapore, June 15, 2012: In support of its commitment to maximize growth opportunities in China, Eli Lilly has plans ...
Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the ...
Singapore, June 18, 2012: CRO leading company, Quintiles plans to establish a Quintiles regional headquarters for China ...
Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a leading research and development outs...
Singapore: Responding to predicted growth in China's medical industry, Bal Seal Engineering, a leading provider of cust...
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...
Singapore: China Botanic Pharmaceutical revealed its financial results for the three months ending July 31, 2012. During...
